Member Info for dan1nat1

Thanks for the tip L2, when you sold earlier this week did you forget this -

"With the FS at Zinnwald on course to be completed in Q2, we will soon have a first independent valuation for Zinnwald which we are confident will far outstrip our current market capitalisation."

30 is there for the taking, hopefully we break it before news lands. It should then act as a support going forward.

68.5p is the real bid, maybe there are some more 20k buys waiting to be filled.

If everything comes together, with our low free float I would expect £2-£3 as an absolute minimum...but that IF is where the risk is at the moment.

Nice delayed buy from just after close!

Strong finish...shame we couldn't have had another 30 mins trading ;)

And another one right at the close!

30p has been tested a few times over the last few weeks, hopefully we can break it on the next attempt.

£26k nice, is that L2 buying back in ;)

Lets break £1 before we start adding ooo's ;)

Morning Zen,

Re Traumakine and the 35% is that not just the number it will work for irreverent of steroid use? And the hope is Yoda can open that figure higher by not using steroids?

Nice start to the morning!

Maybe start here -

http://www.lse.co.uk/share-regulatory-news.asp?shareprice=EMH&ArticleCode=11racoik&ArticleHeadline=Quarterly_Cashflow_Report

From yesterdays interview it seems Clevegen could be first, and if as stated they do have meetings lined up at Asco we could be just 4 weeks away from an update...I can wait that long ;)

Nice to see a few buys ticking through today.

Would be good if we could break and hold 70p - 75p before the next news lands.

You sold 90% of your BCN at a loss?

This close to two pieces of big news...

This must be what he is talking about re: Clevegen partner -

https://meetings.asco.org/am/register-submit-abstracts

Not exactly sure what he said, but it seemed to me that he said we have cash until the end of Q3 although everything else I have seen says cash to last into Q3. Small point I know but into Q3 and end of Q3 could be 3 months difference.

3.20 min in he talks about meetings early June ref Clevegen partners, very interested to hear if anyone knows what these could be. He say "we have a number of different meetings" and does seem very confident.

Sounds to me like we might get a partner deal on Clevegen before Traumakine...maybe that was just my take on the interview?

With regards to what?

We won’t have any earnings, and everything else we are just guessing about.

We have news due on multiple fronts, if any of it lands on Tuesday and its positive expect a massive jump in SP before we open.

It maybe that they don't announce anything apart from the results, but something has stirred someone into a couple of large buys since yesterday...it's fingers crossed time ;)